img

Global Advanced Cell Therapies Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Advanced Cell Therapies Market Insights, Forecast to 2034

Advanced cell-based therapies are promising approaches for stimulating full regeneration of cartilage lesions.
Market Analysis and InsightsGlobal Advanced Cell Therapies Market
Global Advanced Cell Therapies market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Advanced Cell Therapies industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Advanced Cell Therapies key companies include FRC Blood Service, Fujifilm, Vericel, Advanced Cell Technology, Inc, Locate Bio Limited, Kolon TissueGene, Gamida Cell, Okyanos and Rexgenero, etc. FRC Blood Service, Fujifilm, Vericel are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Advanced Cell Therapies were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Advanced Cell Therapies market and estimated to attract more attentions from industry insiders and investors.
Advanced Cell Therapies can be divided into Stem Cell Transplants and CAR T-cell Therapy, etc. Stem Cell Transplants is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Advanced Cell Therapies is widely used in various fields, such as Stem Cell and Regenerative Medicine, etc. Stem Cell provides greatest supports to the Advanced Cell Therapies industry development. In 2022, global % revenue of Advanced Cell Therapies went into Stem Cell filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Advanced Cell Therapies market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Advanced Cell Therapies market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


FRC Blood Service
Fujifilm
Vericel
Advanced Cell Technology, Inc
Locate Bio Limited
Kolon TissueGene
Gamida Cell
Okyanos
Rexgenero
BioXcellerator
Takura
Autolus
Segment by Type
Stem Cell Transplants
CAR T-cell Therapy

Segment by Application


Stem Cell
Regenerative Medicine
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Advanced Cell Therapies introduction, etc. Advanced Cell Therapies Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Advanced Cell Therapies
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Cell Therapies Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Stem Cell Transplants
1.2.3 CAR T-cell Therapy
1.3 Market by Application
1.3.1 Global Advanced Cell Therapies Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Stem Cell
1.3.3 Regenerative Medicine
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Cell Therapies Market Perspective (2018-2033)
2.2 Global Advanced Cell Therapies Growth Trends by Region
2.2.1 Advanced Cell Therapies Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Advanced Cell Therapies Historic Market Size by Region (2018-2023)
2.2.3 Advanced Cell Therapies Forecasted Market Size by Region (2024-2033)
2.3 Advanced Cell Therapies Market Dynamics
2.3.1 Advanced Cell Therapies Industry Trends
2.3.2 Advanced Cell Therapies Market Drivers
2.3.3 Advanced Cell Therapies Market Challenges
2.3.4 Advanced Cell Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Advanced Cell Therapies by Players
3.1.1 Global Advanced Cell Therapies Revenue by Players (2018-2023)
3.1.2 Global Advanced Cell Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Advanced Cell Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Advanced Cell Therapies, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Advanced Cell Therapies Market Concentration Ratio
3.4.1 Global Advanced Cell Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Cell Therapies Revenue in 2022
3.5 Global Key Players of Advanced Cell Therapies Head office and Area Served
3.6 Global Key Players of Advanced Cell Therapies, Product and Application
3.7 Global Key Players of Advanced Cell Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Cell Therapies Breakdown Data by Type
4.1 Global Advanced Cell Therapies Historic Market Size by Type (2018-2023)
4.2 Global Advanced Cell Therapies Forecasted Market Size by Type (2024-2033)
5 Advanced Cell Therapies Breakdown Data by Application
5.1 Global Advanced Cell Therapies Historic Market Size by Application (2018-2023)
5.2 Global Advanced Cell Therapies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Advanced Cell Therapies Market Size (2018-2033)
6.2 North America Advanced Cell Therapies Market Size by Type
6.2.1 North America Advanced Cell Therapies Market Size by Type (2018-2023)
6.2.2 North America Advanced Cell Therapies Market Size by Type (2024-2033)
6.2.3 North America Advanced Cell Therapies Market Share by Type (2018-2033)
6.3 North America Advanced Cell Therapies Market Size by Application
6.3.1 North America Advanced Cell Therapies Market Size by Application (2018-2023)
6.3.2 North America Advanced Cell Therapies Market Size by Application (2024-2033)
6.3.3 North America Advanced Cell Therapies Market Share by Application (2018-2033)
6.4 North America Advanced Cell Therapies Market Size by Country
6.4.1 North America Advanced Cell Therapies Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Advanced Cell Therapies Market Size by Country (2018-2023)
6.4.3 North America Advanced Cell Therapies Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Advanced Cell Therapies Market Size (2018-2033)
7.2 Europe Advanced Cell Therapies Market Size by Type
7.2.1 Europe Advanced Cell Therapies Market Size by Type (2018-2023)
7.2.2 Europe Advanced Cell Therapies Market Size by Type (2024-2033)
7.2.3 Europe Advanced Cell Therapies Market Share by Type (2018-2033)
7.3 Europe Advanced Cell Therapies Market Size by Application
7.3.1 Europe Advanced Cell Therapies Market Size by Application (2018-2023)
7.3.2 Europe Advanced Cell Therapies Market Size by Application (2024-2033)
7.3.3 Europe Advanced Cell Therapies Market Share by Application (2018-2033)
7.4 Europe Advanced Cell Therapies Market Size by Country
7.4.1 Europe Advanced Cell Therapies Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Advanced Cell Therapies Market Size by Country (2018-2023)
7.4.3 Europe Advanced Cell Therapies Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Advanced Cell Therapies Market Size (2018-2033)
8.2 China Advanced Cell Therapies Market Size by Type
8.2.1 China Advanced Cell Therapies Market Size by Type (2018-2023)
8.2.2 China Advanced Cell Therapies Market Size by Type (2024-2033)
8.2.3 China Advanced Cell Therapies Market Share by Type (2018-2033)
8.3 China Advanced Cell Therapies Market Size by Application
8.3.1 China Advanced Cell Therapies Market Size by Application (2018-2023)
8.3.2 China Advanced Cell Therapies Market Size by Application (2024-2033)
8.3.3 China Advanced Cell Therapies Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Advanced Cell Therapies Market Size (2018-2033)
9.2 Asia Advanced Cell Therapies Market Size by Type
9.2.1 Asia Advanced Cell Therapies Market Size by Type (2018-2023)
9.2.2 Asia Advanced Cell Therapies Market Size by Type (2024-2033)
9.2.3 Asia Advanced Cell Therapies Market Share by Type (2018-2033)
9.3 Asia Advanced Cell Therapies Market Size by Application
9.3.1 Asia Advanced Cell Therapies Market Size by Application (2018-2023)
9.3.2 Asia Advanced Cell Therapies Market Size by Application (2024-2033)
9.3.3 Asia Advanced Cell Therapies Market Share by Application (2018-2033)
9.4 Asia Advanced Cell Therapies Market Size by Region
9.4.1 Asia Advanced Cell Therapies Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Advanced Cell Therapies Market Size by Region (2018-2023)
9.4.3 Asia Advanced Cell Therapies Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Advanced Cell Therapies Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Advanced Cell Therapies Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 FRC Blood Service
11.1.1 FRC Blood Service Company Details
11.1.2 FRC Blood Service Business Overview
11.1.3 FRC Blood Service Advanced Cell Therapies Introduction
11.1.4 FRC Blood Service Revenue in Advanced Cell Therapies Business (2018-2023)
11.1.5 FRC Blood Service Recent Developments
11.2 Fujifilm
11.2.1 Fujifilm Company Details
11.2.2 Fujifilm Business Overview
11.2.3 Fujifilm Advanced Cell Therapies Introduction
11.2.4 Fujifilm Revenue in Advanced Cell Therapies Business (2018-2023)
11.2.5 Fujifilm Recent Developments
11.3 Vericel
11.3.1 Vericel Company Details
11.3.2 Vericel Business Overview
11.3.3 Vericel Advanced Cell Therapies Introduction
11.3.4 Vericel Revenue in Advanced Cell Therapies Business (2018-2023)
11.3.5 Vericel Recent Developments
11.4 Advanced Cell Technology, Inc
11.4.1 Advanced Cell Technology, Inc Company Details
11.4.2 Advanced Cell Technology, Inc Business Overview
11.4.3 Advanced Cell Technology, Inc Advanced Cell Therapies Introduction
11.4.4 Advanced Cell Technology, Inc Revenue in Advanced Cell Therapies Business (2018-2023)
11.4.5 Advanced Cell Technology, Inc Recent Developments
11.5 Locate Bio Limited
11.5.1 Locate Bio Limited Company Details
11.5.2 Locate Bio Limited Business Overview
11.5.3 Locate Bio Limited Advanced Cell Therapies Introduction
11.5.4 Locate Bio Limited Revenue in Advanced Cell Therapies Business (2018-2023)
11.5.5 Locate Bio Limited Recent Developments
11.6 Kolon TissueGene
11.6.1 Kolon TissueGene Company Details
11.6.2 Kolon TissueGene Business Overview
11.6.3 Kolon TissueGene Advanced Cell Therapies Introduction
11.6.4 Kolon TissueGene Revenue in Advanced Cell Therapies Business (2018-2023)
11.6.5 Kolon TissueGene Recent Developments
11.7 Gamida Cell
11.7.1 Gamida Cell Company Details
11.7.2 Gamida Cell Business Overview
11.7.3 Gamida Cell Advanced Cell Therapies Introduction
11.7.4 Gamida Cell Revenue in Advanced Cell Therapies Business (2018-2023)
11.7.5 Gamida Cell Recent Developments
11.8 Okyanos
11.8.1 Okyanos Company Details
11.8.2 Okyanos Business Overview
11.8.3 Okyanos Advanced Cell Therapies Introduction
11.8.4 Okyanos Revenue in Advanced Cell Therapies Business (2018-2023)
11.8.5 Okyanos Recent Developments
11.9 Rexgenero
11.9.1 Rexgenero Company Details
11.9.2 Rexgenero Business Overview
11.9.3 Rexgenero Advanced Cell Therapies Introduction
11.9.4 Rexgenero Revenue in Advanced Cell Therapies Business (2018-2023)
11.9.5 Rexgenero Recent Developments
11.10 BioXcellerator
11.10.1 BioXcellerator Company Details
11.10.2 BioXcellerator Business Overview
11.10.3 BioXcellerator Advanced Cell Therapies Introduction
11.10.4 BioXcellerator Revenue in Advanced Cell Therapies Business (2018-2023)
11.10.5 BioXcellerator Recent Developments
11.11 Takura
11.11.1 Takura Company Details
11.11.2 Takura Business Overview
11.11.3 Takura Advanced Cell Therapies Introduction
11.11.4 Takura Revenue in Advanced Cell Therapies Business (2018-2023)
11.11.5 Takura Recent Developments
11.12 Autolus
11.12.1 Autolus Company Details
11.12.2 Autolus Business Overview
11.12.3 Autolus Advanced Cell Therapies Introduction
11.12.4 Autolus Revenue in Advanced Cell Therapies Business (2018-2023)
11.12.5 Autolus Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Advanced Cell Therapies Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Stem Cell Transplants
Table 3. Key Players of CAR T-cell Therapy
Table 4. Global Advanced Cell Therapies Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Advanced Cell Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Advanced Cell Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Advanced Cell Therapies Market Share by Region (2018-2023)
Table 8. Global Advanced Cell Therapies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Advanced Cell Therapies Market Share by Region (2024-2033)
Table 10. Advanced Cell Therapies Market Trends
Table 11. Advanced Cell Therapies Market Drivers
Table 12. Advanced Cell Therapies Market Challenges
Table 13. Advanced Cell Therapies Market Restraints
Table 14. Global Advanced Cell Therapies Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Advanced Cell Therapies Revenue Share by Players (2018-2023)
Table 16. Global Top Advanced Cell Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Cell Therapies as of 2022)
Table 17. Global Advanced Cell Therapies Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Advanced Cell Therapies Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Advanced Cell Therapies, Headquarters and Area Served
Table 20. Global Key Players of Advanced Cell Therapies, Product and Application
Table 21. Global Key Players of Advanced Cell Therapies, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Advanced Cell Therapies Revenue Market Share by Type (2018-2023)
Table 25. Global Advanced Cell Therapies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Advanced Cell Therapies Revenue Market Share by Type (2024-2033)
Table 27. Global Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Advanced Cell Therapies Revenue Share by Application (2018-2023)
Table 29. Global Advanced Cell Therapies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Advanced Cell Therapies Revenue Share by Application (2024-2033)
Table 31. North America Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Advanced Cell Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Advanced Cell Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Advanced Cell Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Advanced Cell Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Advanced Cell Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Advanced Cell Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Advanced Cell Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Advanced Cell Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Advanced Cell Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Advanced Cell Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Advanced Cell Therapies Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Advanced Cell Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Advanced Cell Therapies Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Advanced Cell Therapies Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 63. FRC Blood Service Company Details
Table 64. FRC Blood Service Business Overview
Table 65. FRC Blood Service Advanced Cell Therapies Product
Table 66. FRC Blood Service Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 67. FRC Blood Service Recent Developments
Table 68. Fujifilm Company Details
Table 69. Fujifilm Business Overview
Table 70. Fujifilm Advanced Cell Therapies Product
Table 71. Fujifilm Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 72. Fujifilm Recent Developments
Table 73. Vericel Company Details
Table 74. Vericel Business Overview
Table 75. Vericel Advanced Cell Therapies Product
Table 76. Vericel Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 77. Vericel Recent Developments
Table 78. Advanced Cell Technology, Inc Company Details
Table 79. Advanced Cell Technology, Inc Business Overview
Table 80. Advanced Cell Technology, Inc Advanced Cell Therapies Product
Table 81. Advanced Cell Technology, Inc Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 82. Advanced Cell Technology, Inc Recent Developments
Table 83. Locate Bio Limited Company Details
Table 84. Locate Bio Limited Business Overview
Table 85. Locate Bio Limited Advanced Cell Therapies Product
Table 86. Locate Bio Limited Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 87. Locate Bio Limited Recent Developments
Table 88. Kolon TissueGene Company Details
Table 89. Kolon TissueGene Business Overview
Table 90. Kolon TissueGene Advanced Cell Therapies Product
Table 91. Kolon TissueGene Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 92. Kolon TissueGene Recent Developments
Table 93. Gamida Cell Company Details
Table 94. Gamida Cell Business Overview
Table 95. Gamida Cell Advanced Cell Therapies Product
Table 96. Gamida Cell Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 97. Gamida Cell Recent Developments
Table 98. Okyanos Company Details
Table 99. Okyanos Business Overview
Table 100. Okyanos Advanced Cell Therapies Product
Table 101. Okyanos Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 102. Okyanos Recent Developments
Table 103. Rexgenero Company Details
Table 104. Rexgenero Business Overview
Table 105. Rexgenero Advanced Cell Therapies Product
Table 106. Rexgenero Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 107. Rexgenero Recent Developments
Table 108. BioXcellerator Company Details
Table 109. BioXcellerator Business Overview
Table 110. BioXcellerator Advanced Cell Therapies Product
Table 111. BioXcellerator Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 112. BioXcellerator Recent Developments
Table 113. Takura Company Details
Table 114. Takura Business Overview
Table 115. Takura Advanced Cell Therapies Product
Table 116. Takura Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 117. Takura Recent Developments
Table 118. Autolus Company Details
Table 119. Autolus Business Overview
Table 120. Autolus Advanced Cell Therapies Product
Table 121. Autolus Revenue in Advanced Cell Therapies Business (2018-2023) & (US$ Million)
Table 122. Autolus Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Advanced Cell Therapies Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Advanced Cell Therapies Market Share by Type: 2022 VS 2033
Figure 3. Stem Cell Transplants Features
Figure 4. CAR T-cell Therapy Features
Figure 5. Global Advanced Cell Therapies Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Advanced Cell Therapies Market Share by Application: 2022 VS 2033
Figure 7. Stem Cell Case Studies
Figure 8. Regenerative Medicine Case Studies
Figure 9. Advanced Cell Therapies Report Years Considered
Figure 10. Global Advanced Cell Therapies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Advanced Cell Therapies Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Advanced Cell Therapies Market Share by Region: 2022 VS 2033
Figure 13. Global Advanced Cell Therapies Market Share by Players in 2022
Figure 14. Global Top Advanced Cell Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Cell Therapies as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Advanced Cell Therapies Revenue in 2022
Figure 16. North America Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Advanced Cell Therapies Market Share by Type (2018-2033)
Figure 18. North America Advanced Cell Therapies Market Share by Application (2018-2033)
Figure 19. North America Advanced Cell Therapies Market Share by Country (2018-2033)
Figure 20. United States Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Advanced Cell Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 23. Europe Advanced Cell Therapies Market Share by Type (2018-2033)
Figure 24. Europe Advanced Cell Therapies Market Share by Application (2018-2033)
Figure 25. Europe Advanced Cell Therapies Market Share by Country (2018-2033)
Figure 26. Germany Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. China Advanced Cell Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 33. China Advanced Cell Therapies Market Share by Type (2018-2033)
Figure 34. China Advanced Cell Therapies Market Share by Application (2018-2033)
Figure 35. Asia Advanced Cell Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Asia Advanced Cell Therapies Market Share by Type (2018-2033)
Figure 37. Asia Advanced Cell Therapies Market Share by Application (2018-2033)
Figure 38. Asia Advanced Cell Therapies Market Share by Region (2018-2033)
Figure 39. Japan Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Taiwan Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Advanced Cell Therapies Market Size YoY (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Advanced Cell Therapies Market Share by Type (2018-2033)
Figure 47. Middle East, Africa, and Latin America Advanced Cell Therapies Market Share by Application (2018-2033)
Figure 48. Middle East, Africa, and Latin America Advanced Cell Therapies Market Share by Country (2018-2033)
Figure 49. Brazil Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Mexico Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Turkey Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Israel Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GCC Countries Advanced Cell Therapies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. FRC Blood Service Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 56. Fujifilm Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 57. Vericel Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 58. Advanced Cell Technology, Inc Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 59. Locate Bio Limited Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 60. Kolon TissueGene Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 61. Gamida Cell Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 62. Okyanos Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 63. Rexgenero Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 64. BioXcellerator Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 65. Takura Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 66. Autolus Revenue Growth Rate in Advanced Cell Therapies Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries